These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12534094)

  • 21. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 22. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F; Michaud K; Burke TA; Zhao SZ
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed pinpoint purpura after fractionated carbon dioxide treatment in a patient taking ibuprofen in the postoperative period.
    Fife DJ; Zachary CB
    Dermatol Surg; 2009 Mar; 35(3):553. PubMed ID: 19250302
    [No Abstract]   [Full Text] [Related]  

  • 25. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
    Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
    Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute renal failure associated with amoxicillin and ibuprofen in an 11-year-old boy.
    Primack WA; Rahman SM; Pullman J
    Pediatr Nephrol; 1997 Feb; 11(1):125-6. PubMed ID: 9035187
    [No Abstract]   [Full Text] [Related]  

  • 27. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 28. [General practice study of back and joint pain. Good grades for a new nonsteroidal anti-inflammatory drug].
    MMW Fortschr Med; 2002 Sep; 144(38):60. PubMed ID: 12395715
    [No Abstract]   [Full Text] [Related]  

  • 29. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the use of specific isomers improve the safety and efficacy of nonsteroidal antiinflammatory drugs?
    White PF
    Anesth Analg; 2003 Aug; 97(2):309-310. PubMed ID: 12873909
    [No Abstract]   [Full Text] [Related]  

  • 31. Do we need to incorporate pharmacogenetics in randomized, controlled trials of frequently used medicines?
    van den Anker JN
    Pediatrics; 2007 Jul; 120(1):237; author reply 237-8. PubMed ID: 17606585
    [No Abstract]   [Full Text] [Related]  

  • 32. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commercially viable resolution of ibuprofen.
    Chávez-Flores D; Salvador JM
    Biotechnol J; 2009 Aug; 4(8):1222-4. PubMed ID: 19455529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Licofelone (Merckle).
    Ding C; Cicuttini F
    IDrugs; 2003 Aug; 6(8):802-8. PubMed ID: 12917777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weak opiate analgesics: modest practical merits.
    Prescrire Int; 2004 Feb; 13(69):22-5. PubMed ID: 15055224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecule of the month. MPC-7869 (Flurizan).
    Drug News Perspect; 2005 Mar; 18(2):141. PubMed ID: 15883622
    [No Abstract]   [Full Text] [Related]  

  • 37. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
    Chen JT; Pucino F; Resman-Targoff BH
    J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of skin reactions when using ibuprofen-based medicines.
    Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
    Expert Opin Drug Saf; 2005 Sep; 4(5):837-48. PubMed ID: 16111447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal tolerability of non-steroidal drugs (NSAIDS) in newborn infants].
    Fornaro M; Cuzzolin L; Fanos V
    Pediatr Med Chir; 2004; 26(6):423-9. PubMed ID: 16363767
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.
    Goldstein JL; Eisen GM; Agrawal N; Stenson WF; Kent JD; Verburg KM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):527-38. PubMed ID: 15339324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.